Adicet Bio to Present at Upcoming Investor Conferences

Rhea-AI Summary

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company, announced participation in two investor conferences in May and June 2022. The H.C. Wainwright Global Investment Conference will occur from May 23-26, with an on-demand presentation available from May 24 at 7:00 A.M. ET. The Jefferies Healthcare Conference runs from June 8-10, featuring a presentation by CEO Chen Schor on June 10 at 8:30 A.M. ET. Live webcasts will be accessible via Adicet’s Investors section on their website.

MENLO PARK, Calif. & BOSTON--(BUSINESS WIRE)-- Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing first-in-class allogeneic gamma delta chimeric antigen receptor (CAR) T cell therapies for cancer, today announced that company management will participate in two upcoming investor conferences in May and June.

Details of the events are as follows:

H.C. Wainwright Global Investment Conference, May 23-26, 2022

• An on-demand presentation will be available beginning Tuesday, May 24^th, 2022, at 7:00 A.M. ET.

Jefferies Healthcare Conference, June 8-10, 2022

• Chen Schor, President & CEO, will present on Friday, June 10, 2022 at 8:30 A.M. ET.

The live audio webcast of the presentations can be accessed on the Investors section of Adicet Bio’s website at https://investor.adicetbio.com. An archived replay will be available for 30 days following the presentation.

About Adicet Bio, Inc.

Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with CAR and T cell receptor-like targeting moieties to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. For more information, please visit our website at http://www.adicetbio.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220518005854/en/

Adicet Bio., Inc.

Investor and Media Contacts

Anne Bowdidge

abowdidge@adicetbio.com

Janhavi Mohite

Stern Investor Relations, Inc.

212-362-1200

janhavi.mohite@sternir.com

Source: Adicet Bio, Inc.

FAQ

When will Adicet Bio participate in the H.C. Wainwright Global Investment Conference?

Adicet Bio will participate in the H.C. Wainwright Global Investment Conference from May 23-26, 2022.

What is the schedule for Adicet Bio's presentations at the investor conferences?

Adicet Bio’s presentation at the H.C. Wainwright conference will be available on-demand starting May 24, 2022. The CEO will present at the Jefferies Healthcare Conference on June 10, 2022, at 8:30 A.M. ET.

How can I access the live audio webcasts of Adicet Bio's presentations?

The live audio webcasts of Adicet Bio’s presentations can be accessed on the Investors section of their website.

What is Adicet Bio, and what do they focus on?

Adicet Bio is a biotechnology company focused on developing allogeneic gamma delta T cell therapies for cancer.

What are the dates for the Jefferies Healthcare Conference where Adicet Bio will present?

The Jefferies Healthcare Conference is scheduled for June 8-10, 2022.